EUVIMEDEUVIMED entdecken
Crossref

Carbetocin versus Oxytocin in Active Management of Third Stage of Labour

Simran Rani, Amrita Rai, Rupam Sinha, Geeta Sinha

International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)

DOI: 10.25258/ijcpr.18.6.212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Simran Rani und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

One of the leading causes of maternal morbidity and mortality is still postpartum hemorrhage (PPH). The incidence of PPH is significantly reduced by active management of the third stage of labor (AMTSL) with uterotonic drugs. The most common uterotonic, oxytocin, may require repeated doses due to its brief duration of effect. A single dose of carbetocin, a long-acting oxytocin mimic, provides prolonged uterine contraction.

Methods

An interventional clinical trial was conducted in the Department of Obstetrics and Gynaecology, PMCH, Patna, Bihar from September 2022 to April 2024 for comparison of heat stable carbetocin versus oxytocin in an attempt to determine the more efficacious drug for active management of third stage of labour. A total of 200 pregnant women were divided into 2 groups, Group A {Carbetocin group} with 50 cases of vaginal deliveries and 50 cases of caesarean section who were given IV bolus of 100 µg of Carbetocin and Group B {Oxytocin group} with 50 cases of vaginal deliveries and 50 cases of caesarean section who were administered 10 IU of Oxytocin IM. Comparison was done regarding the efficacy of both drugs in prevention of blood loss on the basis of estimated amount of blood loss, tonicity, time taken to achieve good tone, hemoglobin levels before and after delivery, Reduction in hemoglobin levels, occurrence of PPH, need of other uterotonic agents and need of blood transfusion.

Results

Mean blood loss in the 1st 24 hours postpartum was significantly lower in the carbetocin group compared to the oxytocin group (485.5±299.02 ml versus 514.5±350.49 ml; p=0.581). Comparison of estimated amount of blood loss between Carbetocin and Oxytocin group {Vaginal delivery} was (296±173.45 ml versus 321±221.33 ml; p=0.564). Comparison of estimated amount of blood loss between Carbetocin and Oxytocin group {Caesarean section} was (669±282.1 ml versus 708±350.42 ml; p=0.739).

Conclusion

Therefore, it can be concluded that Injection Carbetocin has the potential to become the drug of choice for active management of third stage of labour. It is more efficient than oxytocin in maintaining uterine tone in less time which is a crucial component in active management of third stage of labour.

Zitieren

APA

Rani, S., Rai, A., Sinha, R., & Sinha, G. (2026). Carbetocin versus Oxytocin in Active Management of Third Stage of Labour. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.212

Vancouver

Rani S, Rai A, Sinha R, Sinha G. Carbetocin versus Oxytocin in Active Management of Third Stage of Labour. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.212

BibTeX
@article{Rani2026,
  author = {Rani, Simran and Rai, Amrita and Sinha, Rupam and Sinha, Geeta},
  title = {Carbetocin versus Oxytocin in Active Management of Third Stage of Labour},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {06},
  doi = {10.25258/ijcpr.18.6.212}
}
Kostenlos starten →